Cargando…
Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases
Metabolic syndrome (MetS) is a cluster of metabolic risk factors associated with central obesity, hyperglycemia, insulin resistance, dyslipidemia and high blood pressure. In recent decades, because of the remarkable increase in both prevalence and severity, MetS and its related diseases such as card...
Autores principales: | Nguyen, Thi Thanh Binh, Jin, Yan Yan, Chung, Hea-Jong, Hong, Seong-Tschool |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151620/ https://www.ncbi.nlm.nih.gov/pubmed/29064399 http://dx.doi.org/10.3390/molecules22101795 |
Ejemplares similares
-
The Pharmabiotic Approach to Treat Hyperammonemia
por: Liu, Jing, et al.
Publicado: (2018) -
Rational Design of Improved Pharmabiotics
por: Sleator, Roy D., et al.
Publicado: (2009) -
Blood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease
por: Jin, Yan Yan, et al.
Publicado: (2018) -
Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective
por: Giron, Fanny, et al.
Publicado: (2018) -
Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders
por: María Remes Troche, José, et al.
Publicado: (2020)